Phase 1 study of polyethylene glycol formulation of interferon alpha-2b (Schering 54 031) in Philadelphia chromosome-positive chronic myelogenous leukemia. - Talpaz,M.; O’Brien,S.; Rose,E.; Gupta,S.; Shan,J.; Cortes,J.; Giles,F.J.; Faderl,S.; Kantarjian,H.M. (Blood, 2001)